Zdrowie i gospodarka · 09/04/2002

Public Informational Meeting on Antimicrobial Resistance

The Food and Drug Administration (FDA) is announcing the following meeting: "Public Informational Meeting on Antimicrobial Resistance." The purpose of this public meeting is to provide the general public the opportunity to hear speakers from the agency, industry, and others to provide information on the issue of antimicrobial resistance so the public can fully participate in the public dialogue about the issue. Attendees will be invited to ask questions during the meeting. Date and Time: The meeting will be held on April 26, 2002, from 9:30 a.m. to 4:30 p.m. Walk-in registration will begin at 9 a.m. You may submit written or electronic comments at any time, but in order for your comments to be included with others in conjunction with this meeting, please submit comments no later than 180 days after the meeting. Please include the Docket No. 02N-0037 on your comments. Addresses: The meeting will be held at the Capital Hilton Hotel, Congressional Room, 1001 16th St. (16th and K Sts.), Washington, DC, 202-393-1000. Submit written comments to the Dockets Management Branch (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Submit electronic commen